On December 18, the 2022 (39th) National Pharmaceutical Industry Information Annual Conference hosted by the China Pharmaceutical Industry Information Center was held in Shanghai. The 2021 list of China's top 100 pharmaceutical industry enterprises was presented at the conference.
Five pharmaceutical companies from our province Shiyao Holding Group Co., Ltd., North China Pharmaceutical Group Co., Ltd., Shijiazhuang Yiling Pharmaceutical Co., Ltd., Shijiazhuang Yiling Pharmaceutical Co., Ltd., and Shenwei Pharmaceutical Group Co., Ltd. were selected for the top 100 list, ranking 9th, 32nd, 33rd, 59th and 84th respectively in the top 100 list. At the same time, Shiyao Group and Shijiazhuang Siyao were also named the best industrial enterprises in China's pharmaceutical R&D product line in 2022.
According to information, the enterprises shortlisted in the top 100 pharmaceutical industry in our province have greatly improved their innovation ability, development scale, market influence, and industrial concentration compared to 2020, and progress has been significant. Among them, Shijiazhuang Siyao grew rapidly, rising 13 places from 2020, Shenwei Pharmaceutical rose 8 places, and Shiyao Group rose 1 place.
The“China Pharmaceutical Industry Top 100 Enterprises of the Year” selection campaign organized by the China Pharmaceutical Industry Information Center is the most authoritative and socially influential professional selection in China's pharmaceutical industry. The selection is based on national statistics, combined with indices such as new drug innovation, development potential, and market focus of enterprises, and is ranked based on the legal entities of industrial enterprises, and is highly authoritative and guiding in the industry. (Reporter Ma Yanming)